Calamos Wealth Management LLC increased its position in Danaher Corporation (NYSE:DHR – Free Report) by 41.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 85,624 shares of the conglomerate’s stock after purchasing an additional 24,888 shares during the quarter. Calamos Wealth Management LLC’s holdings in Danaher were worth $16,976,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Meridian Financial Partners LLC bought a new position in shares of Danaher during the 3rd quarter worth about $896,000. Aljian Capital Management LLC increased its stake in Danaher by 8.9% in the third quarter. Aljian Capital Management LLC now owns 3,830 shares of the conglomerate’s stock valued at $759,000 after acquiring an additional 313 shares during the period. Hunter Associates Investment Management LLC raised its position in Danaher by 16.0% in the third quarter. Hunter Associates Investment Management LLC now owns 1,215 shares of the conglomerate’s stock worth $240,000 after purchasing an additional 168 shares in the last quarter. Forefront Wealth Partners LLC bought a new position in Danaher during the third quarter worth about $292,000. Finally, Ascent Group LLC lifted its stake in Danaher by 120.8% during the third quarter. Ascent Group LLC now owns 9,912 shares of the conglomerate’s stock worth $1,965,000 after purchasing an additional 5,422 shares during the period. Institutional investors own 79.05% of the company’s stock.
Insiders Place Their Bets
In other news, SVP Brian W. Ellis sold 21,776 shares of the business’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the completion of the sale, the senior vice president owned 14,553 shares in the company, valued at $3,190,454.19. The trade was a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Teri List sold 3,298 shares of the firm’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the transaction, the director owned 20,762 shares in the company, valued at approximately $4,702,593. This represents a 13.71% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 30,248 shares of company stock valued at $6,609,663. 11.20% of the stock is currently owned by corporate insiders.
Danaher Stock Performance
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the prior year, the company earned $1.71 EPS. The firm’s quarterly revenue was up 4.4% on a year-over-year basis. On average, equities research analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, December 26th. Danaher’s payout ratio is 26.39%.
Analyst Ratings Changes
A number of brokerages have recently issued reports on DHR. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a report on Monday. Royal Bank Of Canada set a $241.00 price target on Danaher in a research report on Tuesday, September 2nd. JPMorgan Chase & Co. increased their price objective on Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Barclays lifted their price objective on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Finally, The Goldman Sachs Group assumed coverage on shares of Danaher in a report on Tuesday, December 9th. They issued a “buy” rating and a $265.00 target price on the stock. Twenty-one analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average price target of $248.25.
Read Our Latest Research Report on DHR
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
